Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Southwest Airlines Co (LUV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Southwest Airlines Co — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B), while Southwest Airlines Co trades at $39.64 (market cap $19.25B). The key difference: Southwest Airlines Co is far larger — about 2.2× Kymera Therapeutics Inc. Common Stock's market cap, and Southwest Airlines Co pays a 1.83% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Southwest Airlines Co for 66 Days on average.
| KYMR | LUV | |
|---|---|---|
Market Cap | $8.87B | $19.25B |
Volume | 779,107 | 5,914,138 |
Sector | Health | Industrials |
52-Week High | $127.31 | $54.80 |
52-Week Low | $55.80 | $29.67 |
Typical Hold Time | 0 Days | 66 Days |
Enterprise Value | $8.26B | $22.34B |
Dividend Yield | — | 1.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Southwest Airlines (LUV) trades at $40.65, down 0.27% on the day, with technical indicators showing a bearish trend while fundamentals reveal a mixed picture. The company reported revenue growth to $28.06 billion in 2025 but saw net income margin compression to 1.57%. Recent earnings show volatility with a significant Q2 2026 beat but a Q1 2026 miss. Analyst sentiment is divided with 42% buy ratings and a $49.61 consensus price target representing 22% upside potential.
LUV presents a value opportunity with attractive valuation metrics (P/S 0.71, EV/EBITDA 8.28) and ongoing commercial transformation driving revenue growth. However, investors face risks from fuel cost volatility, competitive pressures, and inconsistent earnings performance. The stock's current technical weakness near support levels may offer entry points for long-term investors betting on the company's premium service initiatives and projected 2026 margin improvement to 2.78%.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Southwest Airlines Co
Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →
